Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 322

1.

Tumour interstitial fluid pressure may regulate angiogenic factors in osteosarcoma.

Nathan SS, Huvos AG, Casas-Ganem JE, Yang R, Linkov I, Sowers R, DiResta GR, Gorlick R, Healey JH.

Ann Acad Med Singapore. 2009 Dec;38(12):1041-7.

2.

Tumor interstitial fluid pressure may regulate angiogenic factors in osteosarcoma.

Nathan SS, Huvos AG, Casas-Ganem JE, Yang R, Linkov I, Sowers R, DiResta GR, Gorlick R, Healey JH.

J Orthop Res. 2008 Nov;26(11):1520-5. doi: 10.1002/jor.20633.

3.

Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma.

Kubo T, Piperdi S, Rosenblum J, Antonescu CR, Chen W, Kim HS, Huvos AG, Sowers R, Meyers PA, Healey JH, Gorlick R.

Cancer. 2008 May 15;112(10):2119-29. doi: 10.1002/cncr.23437.

4.

Multifocal synchronous low-grade intramedullary and juxtacortical osteogenic sarcoma.

Arkader A, Huvos AG, Healey JH.

Clin Orthop Relat Res. 2007 Dec;465:265-70. Review.

PMID:
17906589
5.

The folate receptor alpha is frequently overexpressed in osteosarcoma samples and plays a role in the uptake of the physiologic substrate 5-methyltetrahydrofolate.

Yang R, Kolb EA, Qin J, Chou A, Sowers R, Hoang B, Healey JH, Huvos AG, Meyers PA, Gorlick R.

Clin Cancer Res. 2007 May 1;13(9):2557-67.

6.

Over-expression of parathyroid hormone Type 1 receptor confers an aggressive phenotype in osteosarcoma.

Yang R, Hoang BH, Kubo T, Kawano H, Chou A, Sowers R, Huvos AG, Meyers PA, Healey JH, Gorlick R.

Int J Cancer. 2007 Sep 1;121(5):943-54.

7.

Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.

Nathan SS, Gorlick R, Bukata S, Chou A, Morris CD, Boland PJ, Huvos AG, Meyers PA, Healey JH.

Cancer. 2006 Oct 1;107(7):1607-16.

8.

18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.

Schöder H, Carlson DL, Kraus DH, Stambuk HE, Gönen M, Erdi YE, Yeung HW, Huvos AG, Shah JP, Larson SM, Wong RJ.

J Nucl Med. 2006 May;47(5):755-62.

9.

Leydig cell tumor after treatment for Ewing's sarcoma.

Butros LJ, Phillip S, Chou A, Meyers PA, Huvos AG, Healey JH, Russo P, Gorlick RG.

Pediatr Blood Cancer. 2007 Dec;49(7):1008-10.

PMID:
16526050
10.

Computed tomographic scan of the chest underestimates the number of metastatic lesions in osteosarcoma.

Kayton ML, Huvos AG, Casher J, Abramson SJ, Rosen NS, Wexler LH, Meyers P, LaQuaglia MP.

J Pediatr Surg. 2006 Jan;41(1):200-6; discussion 200-6.

PMID:
16410133
11.

Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience.

Chou AJ, Merola PR, Wexler LH, Gorlick RG, Vyas YM, Healey JH, LaQuaglia MP, Huvos AG, Meyers PA.

Cancer. 2005 Nov 15;104(10):2214-21.

12.

De novo osteogenic sarcoma in patients older than forty: benefit of multimodality therapy.

Manoso MW, Healey JH, Boland PJ, Athanasian EA, Maki RG, Huvos AG, Morris CD.

Clin Orthop Relat Res. 2005 Sep;438:110-5.

PMID:
16131878
13.

Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma.

Laverdiere C, Hoang BH, Yang R, Sowers R, Qin J, Meyers PA, Huvos AG, Healey JH, Gorlick R.

Clin Cancer Res. 2005 Apr 1;11(7):2561-7.

14.

Elevated physiologic tumor pressure promotes proliferation and chemosensitivity in human osteosarcoma.

Nathan SS, DiResta GR, Casas-Ganem JE, Hoang BH, Sowers R, Yang R, Huvos AG, Gorlick R, Healey JH.

Clin Cancer Res. 2005 Mar 15;11(6):2389-97.

15.

An expression signature classifies chemotherapy-resistant pediatric osteosarcoma.

Mintz MB, Sowers R, Brown KM, Hilmer SC, Mazza B, Huvos AG, Meyers PA, Lafleur B, McDonough WS, Henry MM, Ramsey KE, Antonescu CR, Chen W, Healey JH, Daluski A, Berens ME, Macdonald TJ, Gorlick R, Stephan DA.

Cancer Res. 2005 Mar 1;65(5):1748-54.

16.

Methotrexate levels and outcome in osteosarcoma.

Zelcer S, Kellick M, Wexler LH, Shi W, Sankaran M, Lo S, Healey J, Huvos AG, Meyers PA, Gorlick R.

Pediatr Blood Cancer. 2005 Jun 15;44(7):638-42.

PMID:
15704189
17.

Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse.

Huang HY, Illei PB, Zhao Z, Mazumdar M, Huvos AG, Healey JH, Wexler LH, Gorlick R, Meyers P, Ladanyi M.

J Clin Oncol. 2005 Jan 20;23(3):548-58.

PMID:
15659501
18.

Lymphatic malformation of the sphenoid sinus in a pediatric patient.

Bennett G, April M, Huvos AG.

Otolaryngol Head Neck Surg. 2004 Nov;131(5):784-6.

PMID:
15523467
19.

Intraosseous leiomyoma of the ulna. A case report.

Zikria BA, Radevic MR, Jormark SC, Huvos AG, Yang SS.

J Bone Joint Surg Am. 2004 Nov;86(11):2522-5. No abstract available.

PMID:
15523029
20.

VEGF expression in osteosarcoma correlates with vascular permeability by dynamic MRI.

Hoang BH, Dyke JP, Koutcher JA, Huvos AG, Mizobuchi H, Mazza BA, Gorlick R, Healey JH.

Clin Orthop Relat Res. 2004 Sep;(426):32-8.

PMID:
15346048
21.
22.

Epiphyseal osteoblastoma of tibia with xanthomatous stromal reaction.

Zhang X, Bukata SV, Healey JH, Huvos AG.

Ann Diagn Pathol. 2003 Dec;7(6):360-4.

PMID:
15018119
23.

The patterns of relapse in osteosarcoma: the Memorial Sloan-Kettering experience.

Chi SN, Conklin LS, Qin J, Meyers PA, Huvos AG, Healey JH, Gorlick R.

Pediatr Blood Cancer. 2004 Jan;42(1):46-51.

PMID:
14752794
24.

Expression of LDL receptor-related protein 5 (LRP5) as a novel marker for disease progression in high-grade osteosarcoma.

Hoang BH, Kubo T, Healey JH, Sowers R, Mazza B, Yang R, Huvos AG, Meyers PA, Gorlick R.

Int J Cancer. 2004 Mar;109(1):106-11.

25.

Identification of prognostic markers in bone sarcomas using proton-decoupled phosphorus magnetic resonance spectroscopy.

Zakian KL, Shukla-Dave A, Meyers P, Gorlick R, Healey J, Thaler HT, Huvos AG, Panicek DM, Koutcher JA.

Cancer Res. 2003 Dec 15;63(24):9042-7.

26.

Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients.

Kutler DI, Wreesmann VB, Goberdhan A, Ben-Porat L, Satagopan J, Ngai I, Huvos AG, Giampietro P, Levran O, Pujara K, Diotti R, Carlson D, Huryn LA, Auerbach AD, Singh B.

J Natl Cancer Inst. 2003 Nov 19;95(22):1718-21.

PMID:
14625263
27.

Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma.

Lau CC, Harris CP, Lu XY, Perlaky L, Gogineni S, Chintagumpala M, Hicks J, Johnson ME, Davino NA, Huvos AG, Meyers PA, Healy JH, Gorlick R, Rao PH.

Genes Chromosomes Cancer. 2004 Jan;39(1):11-21.

PMID:
14603437
28.

Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults.

Kolb EA, Kushner BH, Gorlick R, Laverdiere C, Healey JH, LaQuaglia MP, Huvos AG, Qin J, Vu HT, Wexler L, Wolden S, Meyers PA.

J Clin Oncol. 2003 Sep 15;21(18):3423-30.

PMID:
12972518
29.

Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma.

Laverdiere C, Kolb EA, Supko JG, Gorlick R, Meyers PA, Maki RG, Wexler L, Demetri GD, Healey JH, Huvos AG, Goorin AM, Bagatell R, Ruiz-Casado A, Guzman C, Jimeno J, Harmon D.

Cancer. 2003 Aug 15;98(4):832-40.

30.

Clinicopathologic differences in malignant melanoma arising in oral squamous and sinonasal respiratory mucosa of the upper aerodigestive tract.

Prasad ML, Busam KJ, Patel SG, Hoshaw-Woodard S, Shah JP, Huvos AG.

Arch Pathol Lab Med. 2003 Aug;127(8):997-1002.

PMID:
12873174
31.

Osteogenic and Ewing sarcomas: estimation of necrotic fraction during induction chemotherapy with dynamic contrast-enhanced MR imaging.

Dyke JP, Panicek DM, Healey JH, Meyers PA, Huvos AG, Schwartz LH, Thaler HT, Tofts PS, Gorlick R, Koutcher JA, Ballon D.

Radiology. 2003 Jul;228(1):271-8.

PMID:
12832588
32.

Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma.

Ulaner GA, Huang HY, Otero J, Zhao Z, Ben-Porat L, Satagopan JM, Gorlick R, Meyers P, Healey JH, Huvos AG, Hoffman AR, Ladanyi M.

Cancer Res. 2003 Apr 15;63(8):1759-63.

33.

Metachronous skeletal osteosarcoma in patients treated with adjuvant and neoadjuvant chemotherapy for nonmetastatic osteosarcoma.

Aung L, Gorlick R, Healey JH, Shi W, Thaler HT, Shorter NA, Huvos AG, Meyers PA.

J Clin Oncol. 2003 Jan 15;21(2):342-8.

PMID:
12525528
34.

High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia.

Kutler DI, Auerbach AD, Satagopan J, Giampietro PF, Batish SD, Huvos AG, Goberdhan A, Shah JP, Singh B.

Arch Otolaryngol Head Neck Surg. 2003 Jan;129(1):106-12.

PMID:
12525204
35.

Second malignant neoplasms in long-term survivors of osteosarcoma: Memorial Sloan-Kettering Cancer Center Experience.

Aung L, Gorlick RG, Shi W, Thaler H, Shorter NA, Healey JH, Huvos AG, Meyers PA.

Cancer. 2002 Oct 15;95(8):1728-34.

36.

Improved outcomes in patients with osteogenic sarcoma of the head and neck.

Patel SG, Meyers P, Huvos AG, Wolden S, Singh B, Shaha AR, Boyle JO, Pfister D, Shah JP, Kraus DH.

Cancer. 2002 Oct 1;95(7):1495-503.

37.

Intraoral presentation of Rosai-Dorfman disease: a case report and review of the literature.

Kademani D, Patel SG, Prasad ML, Huvos AG, Shah JP.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Jun;93(6):699-704. Review.

PMID:
12142877
38.

Prognostic factors for malignant melanoma of the squamous mucosa of the head and neck.

Prasad ML, Patel S, Hoshaw-Woodard S, Escrig M, Shah JP, Huvos AG, Busam KJ.

Am J Surg Pathol. 2002 Jul;26(7):883-92.

PMID:
12131155
39.

Low-grade osteogenic sarcoma arising in medullary and surface osseous locations.

Antonescu CR, Huvos AG.

Am J Clin Pathol. 2000 Nov;114 Suppl:S90-103. Review.

PMID:
11996175
40.

Irinotecan for pediatric solid tumors: the Memorial Sloan-Kettering experience.

Cosetti M, Wexler LH, Calleja E, Trippett T, LaQuaglia M, Huvos AG, Gerald W, Healey JH, Meyers PA, Gorlick R.

J Pediatr Hematol Oncol. 2002 Feb;24(2):101-5. Review.

PMID:
11990694
41.

Primary mucosal malignant melanoma of the head and neck.

Patel SG, Prasad ML, Escrig M, Singh B, Shaha AR, Kraus DH, Boyle JO, Huvos AG, Busam K, Shah JP.

Head Neck. 2002 Mar;24(3):247-57.

PMID:
11891956
42.

Comparative frequency of bone sarcomas among different racial groups.

Guo W, Xu W, Huvos AG, Healey JH, Feng C.

Chin Med J (Engl). 1999 Dec;112(12):1101-4.

PMID:
11721448
43.

Tumors of the bones of the feet: the clinicopathologic features of 150 cases.

Bakotic B, Huvos AG.

J Foot Ankle Surg. 2001 Sep-Oct;40(5):277-86.

PMID:
11686448
44.

Lack of correlation of functional scintigraphy with (99m)technetium-methoxyisobutylisonitrile with histological necrosis following induction chemotherapy or measures of P-glycoprotein expression in high-grade osteosarcoma.

Gorlick R, Liao AC, Antonescu C, Huvos AG, Healey JH, Sowers R, Daras M, Calleja E, Wexler LH, Panicek D, Meyers PA, Yeh SD, Larson SM.

Clin Cancer Res. 2001 Oct;7(10):3065-70.

45.

Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa.

Prasad ML, Jungbluth AA, Iversen K, Huvos AG, Busam KJ.

Am J Surg Pathol. 2001 Jun;25(6):782-7.

PMID:
11395556
46.

Role of fine-needle aspiration biopsy and frozen section analysis in the surgical management of thyroid tumors.

Brooks AD, Shaha AR, DuMornay W, Huvos AG, Zakowski M, Brennan MF, Shah J.

Ann Surg Oncol. 2001 Mar;8(2):92-100.

PMID:
11258788
47.

Basaloid squamous cell carcinoma of the head and neck.

Paulino AF, Singh B, Shah JP, Huvos AG.

Laryngoscope. 2000 Sep;110(9):1479-82.

PMID:
10983946
48.

Prognostic impact of INK4A deletion in Ewing sarcoma.

Wei G, Antonescu CR, de Alava E, Leung D, Huvos AG, Meyers PA, Healey JH, Ladanyi M.

Cancer. 2000 Aug 15;89(4):793-9.

PMID:
10951342
49.

Prognostic impact of P53 status in Ewing sarcoma.

de Alava E, Antonescu CR, Panizo A, Leung D, Meyers PA, Huvos AG, Pardo-Mindán FJ, Healey JH, Ladanyi M.

Cancer. 2000 Aug 15;89(4):783-92.

PMID:
10951341
50.

Myoepithelial carcinoma of the salivary glands: a clinicopathologic study of 25 patients.

Savera AT, Sloman A, Huvos AG, Klimstra DS.

Am J Surg Pathol. 2000 Jun;24(6):761-74.

PMID:
10843278

Supplemental Content

Loading ...
Support Center